From July 1, 2023 to September 14, 2023, the company has repurchased 261,000 shares, representing 0.06% for CNY 5.03 million. With this, the company has completed the repurchase of 1,426,700 shares, representing 0.33% for CNY 30.03 million under the buyback announced on April 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% |
|
-.--% | -45.40% |
25/06 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark | MT |
24/06 | Hainan Poly Pharm Gets US FDA Marketing Nod for Antibacterial Injection | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 762M | |
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.